Navigation Links
Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer
Date:4/28/2008

- Dr. Sylvie Bouchard to Retire from Company -

LAVAL, QC, April 28 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that Claire Brulle, M.D. has been appointed Senior Vice-President and Chief Medical Officer of the Company. Incumbent Chief Medical Officer Dr. Sylvie Bouchard has retired from Labopharm Inc. to focus on her career practicing medicine.

"Dr. Brulle brings to Labopharm a proven track record in medical affairs and clinical development and an impressive portfolio of competencies ranging from global clinical development to medical support for commercial operations," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. "With extensive experience interacting with regulatory agencies in both North America and Europe and specific expertise in the area of pain therapeutics, Dr. Brulle is a strong addition to our team as we pursue our objective of commercializing multiple large market opportunity drugs."

Dr. Brulle has more than 25 years experience in the medical profession, including more than 15 years experience in the pharmaceutical industry with Pfizer Inc. During her tenure at Pfizer, Dr. Brulle held a series of increasingly senior medical roles, including lead positions for the Pain and Arthritis Franchise. Dr. Brulle received her Medical Degree from the Universite de Paris and has completed International and Leadership Development Programs from INSEAD Institute and Harvard Business School, respectively.

Mr. Howard-Tripp continued, "Dr. Bouchard's expertise and diligence has been invaluable to Labopharm's success to date. On behalf of the Company and the Board of Directors, I would like to thank her for her very significant contribution to Labopharm and wish her well as a full-time practicing physician."

Dr. Bouchard will continue to be available to Labopharm to transition the role to Dr. Brulle and will act as a consultant to the Company going
'/>"/>

SOURCE Labopharm Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Labopharm Appeals FDAs Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy
2. Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
3. Labopharms Once-Daily Tramadol Approved in South Korea and Australia
4. Labopharm to host conference call Thursday, February 21, 2008 at 8:30 a.m. (ET)
5. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
6. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
7. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm Reports Results for Third Quarter Fiscal 2007
10. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
11. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... of women who are given information about the chance ... not fully understand the risks involved, according to research ... , today (Friday). , In a survey of around ... London (UCL) found that 64 per cent felt they ... chance that screening will pick up cancers that would ...
(Date:8/28/2014)... 28, 2014 Millennium Treatment Group ... September. This month will be a celebration of ... health services. Along with other treatment facilities and ... to spread the word about this national observance. ... the work of treatment and recovery professionals, and ...
(Date:8/28/2014)... August 28, 2014 Millennium Treatment Group ... users in the workplace. A recent report from ... states that drug abuse is costing employers an ... or are addicted to drugs affect their employers and ... over into the workplace, causing expensive problems for their ...
(Date:8/28/2014)... Reinberg HealthDay Reporter THURSDAY, ... the diet may worsen symptoms of multiple sclerosis (MS), a ... MS, such as vitamin D, smoking and Epstein Barr virus ... another environmental factor affecting MS patients," said lead researcher Dr. ... in Buenos Aires. Multiple sclerosis is a disease of ...
(Date:8/28/2014)... 28, 2014 Testimony began this ... a transvaginal mesh lawsuit ( http://www.transvaginalmeshlawsuithelp.com/ )involving ... LLP reports. Court documents pending in the U.S. ... that the case was filed on behalf of ... surgeries, allegedly due to vaginal mesh complications associated ...
Breaking Medicine News(10 mins):Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Drug Use Causes Problems in the Workplace 2Health News:Could Too Much Salt Harm MS Patients? 2Health News:Could Too Much Salt Harm MS Patients? 3Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 4
... risk when taking nortriptyline than escitalopram, study finds , ... the antidepressant nortriptyline (Aventyl) are nearly 10 times more ... the antidepressant escitalopram (Lexapro, Cipralex), a new study has ... BMC Medicine , included 811 people with ...
... 13 , News facts: , ... community for individuals with breast cancer, however the experiences of ... stage of the disease, is rarely discussed., MBC, also ... occurs when cancer has spread beyond the breast to other ...
... Md., Oct. 15 The U.S. Food and Drug ... purchasing any products over the Internet that claim to ... The warning comes after the FDA recently purchased and ... may pose risks to patients. , (Logo: ...
... Oct. 15 Mayo Clinic clinicians and designers, along ... a tool to involve patients more in their diabetes ... decision aid cards, could help patients make decisions involving ... results of this randomized trial are in September,s issue ...
... With national focus on health reform, NY hospital system looks to ... area,s largest automated medical record system , GREAT NECK, ... it is subsidizing up to 85 percent of the cost of ... offices of its more than 7,000 affiliated physicians in New York ...
... will host "S,more to Love", a cocktail fundraiser on Friday, November ... benefit Birch Family Camp. , Celebrating its 20th year, the Birch ... the 5 boroughs of NYC, along with 200 volunteers for a ... located in the Hudson Valley. Throughout the year this community ...
Cached Medicine News:Health News:Video: Cities and States Around the U.S. Recognize October 13 as Metastatic Breast Cancer Awareness Day 2Health News:Video: Cities and States Around the U.S. Recognize October 13 as Metastatic Breast Cancer Awareness Day 3Health News:FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet 2Health News:FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet 3Health News:Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 2Health News:Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 3Health News:Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 4Health News:North Shore-LIJ Health System Investing $400M to Connect Up to 7,000 Physicians, 13 Hospitals with Electronic Health Records System 2Health News:North Shore-LIJ Health System Investing $400M to Connect Up to 7,000 Physicians, 13 Hospitals with Electronic Health Records System 3Health News:North Shore-LIJ Health System Investing $400M to Connect Up to 7,000 Physicians, 13 Hospitals with Electronic Health Records System 4Health News:North Shore-LIJ Health System Investing $400M to Connect Up to 7,000 Physicians, 13 Hospitals with Electronic Health Records System 5Health News:North Shore-LIJ Health System Investing $400M to Connect Up to 7,000 Physicians, 13 Hospitals with Electronic Health Records System 6Health News:North Shore-LIJ Health System Investing $400M to Connect Up to 7,000 Physicians, 13 Hospitals with Electronic Health Records System 7Health News:One Heartland Hosting: S'more to Love Cocktail Fundraiser 2
(Date:8/28/2014)... Colo. , Aug. 28, 2014   Venaxis, ... company focused on obtaining FDA clearance for and commercializing ... blood test for aiding in identifying children, adolescent, and ... at low risk for appendicitis, today announced it will ... Renshaw 16 th Annual Global Investment Conference being ...
(Date:8/28/2014)... 2014  Robotic surgery is creating buzz among ... the promise of improved outcomes and the potential ... surgical robots and market pressures to use this ... their robotic surgery training programs and ensure proper ... ECRI Institute ( www.ecri.org ), a nonprofit ...
(Date:8/28/2014)... , Aug. 28, 2014  Critical Process ... , today announces the expansion of their ... Critical Process Filtration now offers customers and potential ... fluids to filter failure analyses (even for competitor ... to their hallmark services of system benchmarking and ...
Breaking Medicine Technology:Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 2Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 5Critical Process Filtration, Inc. Announces Expanded Technical Services and Validation Support 2
... specifically for detection of recent-onset neovascular ("wet") ... maps and quantifies visual field defects consistent ... to the wet stage of the disease. ... for small visual field defects, the PreView ...
... a new functional test which exhibits 100% ... C Resistance caused by the Factor V ... commercially available methods, Pefakit APC-R FVL shows ... Lupus Anticoagulants, Elevated FVIII levels, Heparins or ...
Cable connections for 5 different adapters: Storz, ACMI, Pentax, Wolf and Olympus....
Lightweight PVC housing for easy transport, integrated handle. Easy lamp exchange....
Medicine Products: